Cargando…

Identifying New Epigenetic Drivers of Liver Fibrosis

Detalles Bibliográficos
Autores principales:	Argemi, Josepmaria, Bataller, Ramon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282870/ https://www.ncbi.nlm.nih.gov/pubmed/30539791 http://dx.doi.org/10.1016/j.jcmgh.2018.09.015

Ejemplares similares

Serum Acylcarnitines Associated with High Short-Term Mortality in Patients with Alcoholic Hepatitis
por: Gao, Bei, et al.
Publicado: (2021)

Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease
por: Ratna, Anuradha, et al.
Publicado: (2021)

Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
por: Stärkel, Peter, et al.
Publicado: (2019)

Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis
por: Rachakonda, Vikrant, et al.
Publicado: (2019)

Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
por: Chen, Jiegen, et al.
Publicado: (2020)

Identifying key multifunctional components shared by critical cancer and normal liver pathways via SparseGMM
por: Bakr, Shaimaa, et al.
Publicado: (2023)

Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD
por: Alvarado-Tapias, Edilmar, et al.
Publicado: (2023)

Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis
por: Martinez-Urbistondo, Diego, et al.
Publicado: (2020)

504. Case SEries: Nasal Antimicrobial Photodisinfection (APDT) as Treatment Protocol for Asymptomatic and Early Stage COVID-19 Patients
por: Kolenda, Jack, et al.
Publicado: (2021)

Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases
por: Gholizadeh, Maryam, et al.
Publicado: (2020)

Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation
por: Jeon, Sookyoung, et al.
Publicado: (2023)

Epigenetics and Liver Fibrosis
por: Moran-Salvador, Eva, et al.
Publicado: (2017)

Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice
por: Correnti, Jason, et al.
Publicado: (2020)

Aberrant Multiciliogenesis in Pulmonary Fibrosis: Bystander or Driver of Disease Progression?
por: Ghanem, Mada, et al.
Publicado: (2022)

Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
por: Alonso-Peña, Marta, et al.
Publicado: (2022)

CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease
por: Duan, Yi, et al.
Publicado: (2021)

Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
por: Guldiken, Nurdan, et al.
Publicado: (2021)

Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant Alone
por: Fernández-Carrillo, Carlos, et al.
Publicado: (2022)

Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis
por: Poulsen, Kyle L., et al.
Publicado: (2021)

The Endothelium as a Driver of Liver Fibrosis and Regeneration
por: Lafoz, Erica, et al.
Publicado: (2020)

In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis
por: Martin-Navarro, Loreto, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
por: Salton, Francesco, et al.
Publicado: (2020)

Epigenetic reprogramming in liver fibrosis and cancer()
por: Wilson, Caroline L., et al.
Publicado: (2017)

Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation
por: Luther, Jay, et al.
Publicado: (2020)

A New Positive Feedback Circuit in the Fibrosis–Cancer Axis for Male Livers
por: Ebrahimkhani, Mo R.
Publicado: (2017)

Runx1: a new driver in neurofibromagenesis
por: Wu, Jianqiang, et al.
Publicado: (2015)

JIND: joint integration and discrimination for automated single-cell annotation
por: Goyal, Mohit, et al.
Publicado: (2022)

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?
por: Caverly, Lindsay J.
Publicado: (2022)

Trends in the management and burden of alcoholic liver disease
por: Mathurin, Philippe, et al.
Publicado: (2015)

PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
por: Theys, Claudia, et al.
Publicado: (2022)

Epigenetic Drivers in Pediatric Medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2017)

New Aspects of the Epigenetics of Pancreatic Carcinogenesis
por: Toruner, Murat, et al.
Publicado: (2020)

Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells
por: Yu, Shan, et al.
Publicado: (2022)

Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values
por: Fernandez-Montero, Alejandro, et al.
Publicado: (2021)

Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease
por: Cast, Ashley, et al.
Publicado: (2019)

A Role for Extracellular Vesicles in Liver Fibrosis
por: Karp, Seth J.
Publicado: (2015)

Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
por: Zhou, Jing-dong, et al.
Publicado: (2020)

A different detection method reveals a new role of alanine aminotransferase as an indicator of liver fibrosis
por: Sung, Pil Soo
Publicado: (2020)

A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits
por: Páramo, María, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_undiotgv3o0fgaqi8mucmr2e4g